Interstitial lung dz Flashcards

1
Q

Respiratory distress syndrome cause

A

Deficiency of surfactant production in immature lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Who does RDS affect?

A

Preterm infants <37 weeks

80% =born before 28 weeks gestation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RDS signs and sx’s

A

Sign of respiratory distress

  • Tachypnea
  • Nasal flaring
  • Cyanosis
  • Expiratory grunting
  • Chest retractions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

RDS treatment

A
  1. Oxygen
  2. CPAP
  3. Surfactant administration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

CXR findings in RDS

A
  1. Low lung volume-hypoexpansion
  2. Reticulogranular “ground glass” appearance
  3. Air bronchograms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What can you give a women to help prevent RDS?

A

Antenatal steroids

Given to all women 23-34 wks gestation @ risk of preterm deliver in next 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Signs and sx’s of mycobacterium avian complex (MAC)

A

Like TB but less severe:

  1. Cough
  2. Dyspnea
  3. Chest discomfort
    * Fever and wt. loss less common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two major clinical presentation of MAC

A
  1. Those with underlying lung disease: White, middle-aged or elderly man, alcoholic and/or smoker with COPD
  2. Those without underlying lung disease: nonsmoking women >50 y.o. who have interstitial pattern on CXR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MAC diagnosis

A
  1. Pulmonary sx’s
  2. Nodular or opacities on CXR
  3. Exclusion of other Dx
  4. Positive cultures from two separate sputum samples
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Indication for MAC treatment with abx?

A
  1. Fibrocavitary dz

2. +/- nodular bronchiectasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MAC abx treatment

A

Azithromycin + Rifampin + Ethambutol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How long do you continue MAC abx treatment for?

A

Until sputum cultures are consecutively negative for @ least 12 months!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical presentation of interstitial lung dz

A

Progressive dyspnea on exertion and nonproductive cough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Physical Exam of interstitial lung dz

A
  1. Crackles
  2. Inspiratory squeaks (high pitched rhonchi)
  3. Cor pulmonale
  4. Cyanosis
  5. Digital clubbing
  6. Extrapulmonary manifestations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

CXR findings in ILD

A
  1. “Ground glass” appearance
  2. Reticular “netlike” opacities
  3. Honeycombing (small cystic spaces)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What CXR findings is a poor prognosis of ILD?

A

Honeycombing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Imaging used for ILD

A

High resolution Chest CT

18
Q

Are most ILD restrictive or obstructive? What would you expect to see on PFTs?

A

Restrictive
Decreased TLC
Decreased FVC
Normal FEV1/FVC ratio (or increased)

19
Q

What is a common and sometimes only findings in ILD in the early stage?

A

Reduced diffusing capacity of lung for carbon monoxide (DLCO)

20
Q

What would you expect to see on an ABG in ILD?

A
  1. Hypoxemia
  2. Respiratory alkalosis
  3. Maybe normal
21
Q

What is the gold standard for a definitive diagnosis for ILD?

A

Lung biopsy

22
Q

Indications for a lung biopsy

A
  1. Atypical or progressive sx’s
  2. Age <50 y.o,
  3. Fever, wt. loss, hemoptysis
  4. ILD sx’s with normal or atypical CXR
23
Q

Complications of ILD

A
  1. Pulmonary HTN–>Cor Pulmonale–>Right heart failure
  2. Pneumothorax
  3. Increased CA risk
  4. Progressive respiratory insufficiency
24
Q

Asbestosis signs and sx’s

A
  1. Dyspnea
  2. Reduced exercise tolerance
  3. Dry cough
25
Asbestosis CXR findings
Opacities in lower lungs Thickened pleura Pleural plaques
26
What population does Sarcoidosis affect 10x more?
African Americans
27
Sarcoidosis physical exam findings
1. Systemic complaints- fever, anorexia, arthralgia 2. Pulmonary- DOE, cough, CP 3. Extrapulmonary- Arthritis, CN palsies, visual disturbances, erythema nodosum
28
CXR findings in sarcoidosis
Bilateral symmetric hilar adenopathy | Right paratracheal mediastinal adenopathy
29
Lab findings in sarcoidosis
1. Increased ACE 2. Increase ESR 3. Increased serum protein 4. ACE
30
sarcoidosis management
1. Consult pulmonologist 2. Symptomatic Tx- NSAIDs 3. Corticosteroids (Prednisone) for severe dz
31
Granulomatosis with Polyangiitis etiology
Immune mediated systemic vasculitis
32
What is characteristic of Granulomatosis with Polyangiitis
Necrotizing granulomas of upper and lower respiratory tracts
33
What is the main organ Granulomatosis with Polyangiitis effects?
Kidneys- Glomerulonephritis
34
What are the most common signs of Granulomatosis with Polyangiitis
Upper airway sx's: - Oral/Nasal ulcers - Sinus pain - Rhinorrhea - Purulent/bloody nasal discharge
35
Pulmonary function in Granulomatosis with Polyangiitis
Restrictive AND obstructive patterns | Decreased DLCO
36
CT findings in Wegener's Granulomatosis
1. Feeding vessels-Blood vessels leading to nodules and cavities 2. "Vasculitis" sign-Irregular and stellate-shaped peripheral pulmonary arteries
37
Lab findings in Granulomatosis with Polyangiitis
Nonspecific: 1. Increased ESR 2. Leukocytosis 3. Thrombocytosis 4. Normocytic anemia 5. Increased BUN/Cr 6. Pos. ANCA (antibodies)
38
Granulomatosis with Polyangiitis management
Consult Rheumatologist - Immunosuppressant: Methotrexate or cyclophosphamide - Glucocorticoid
39
What is the most common of the 7 idiopathic interstitial pneumonias?
Idiopathic Pulmonary Fibrosis
40
What is a risk factor for Idiopathic Pulmonary Fibrosis
Curent or former smoker= 70% of patients
41
What is the most common sign of IPF?
Exertional dyspnea
42
CXR findings in IPF
Bilateral diffuse reticular or reticulonodular infiltrates